Previous studies have found that all carriers of ABCC8 mutations could be switched to sulfonylureas, and this could achieve a reduction in HbA1c.[30] In this case, the initial dose of glimepiride was 4 mg/day to avoid hypoglycemia. This evidence concerns the gene ABCC8 and Hypoglycemia.